Oakworth Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$349K Hold
2,774
0.02% 154
2025
Q1
$307K Hold
2,774
0.02% 165
2024
Q4
$379K Buy
+2,774
New +$379K 0.03% 147